𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine is associated with a decrease in HBV-DNA by PCR

✍ Scribed by P. Honkoop; R.A. de Man; P.E. Zondervan; H.G.M. Niesters; S.W. Schalm


Book ID
116121411
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
134 KB
Volume
48
Category
Article
ISSN
0300-2977

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Quantification of intrahepatic hepatitis
✍ Irene Cacciola; Teresa Pollicino; Giovanni Squadrito; Giovanni Cerenzia; Daniela πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 1 views

No data are available about the amount of hepatitis B virus (HBV) genomes in liver of patients with chronic HBV infection. The aim of this study was to quantify the intrahepatic HBV DNA in hepatitis B surface antigen (HBsAg)-positive patients with either active or suppressed viral replication and in

Frequent detection of hepatitis B virus
✍ S. Gloria Selabe; Ernest Song; Rosemary J. Burnett; M. Jeffrey Mphahlele πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Abstract This retrospective study investigated and characterized the YMDD motif of the hepatitis B virus (HBV) reverse transcriptase (RT) gene, in sequential samples of 17 South African patients with chronic hepatitis B infection on lamivudine treatment. The profile of HBV genotypes as well as t

Characteristics of lamivudine-resistant
✍ Norio Horiike; Tran Nhu Duong; Kojiro Michitaka; Kouji Joko; Yoichi Hiasa; Ichir πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 2 views

## Abstract Lamivudine therapy often causes breakthrough of hepatitis B virus (HBV) DNA and breakthrough hepatitis. The aim of this study was to determine the viral factors that relate to HBV‐DNA breakthrough with and without breakthrough hepatitis. Among 82 patients with chronic hepatitis B (CHB)